Global Heparin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Description

According to our (Global Info Research) latest study, the global Heparin market size was valued at USD 2404.6 million in 2022 and is forecast to a readjusted size of USD 3877.2 million by 2029 with a CAGR of 7.1% during review period.

Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.

In this report, we mainly study the Heparin API.

Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.

The Global Info Research report includes an overview of the development of the Heparin industry chain, the market status of UFH (Heparin Sodium, Heparin Calcium), LMWH (Heparin Sodium, Heparin Calcium), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Heparin.

Regionally, the report analyzes the Heparin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Heparin market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Heparin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Heparin industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (B Units), revenue generated, and market share of different by Type (e.g., Heparin Sodium, Heparin Calcium).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Heparin market.

Regional Analysis: The report involves examining the Heparin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Heparin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Heparin:
Company Analysis: Report covers individual Heparin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Heparin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (UFH, LMWH).

Technology Analysis: Report covers specific technologies relevant to Heparin. It assesses the current state, advancements, and potential future developments in Heparin areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Heparin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Heparin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Heparin Sodium
    Heparin Calcium

Market segment by Application
    UFH
    LMWH

Major players covered
    Shenzhen Hepalink Pharmaceutical
    Yantai Dongcheng Pharmaceutical
    Pfizer
    Bioibérica
    Changzhou Qianhong Biopharma
    Nanjing King-friend Biochemical Pharmaceutical
    Hebei Changshan Biochemical Pharmaceutical
    Qingdao Jiulong Biopharmaceutical
    Opocrin
    Dongying Tiandong Pharmaceutical
    Aspen Oss
    Yino Pharma
    Nanjing Xinbai Pharmaceutical
    Hubei Enoray Biopharmaceutical
    Cisen Pharmaceutical

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Heparin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Heparin, with price, sales, revenue and global market share of Heparin from 2018 to 2023.
Chapter 3, the Heparin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Heparin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Heparin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Heparin.
Chapter 14 and 15, to describe Heparin sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Heparin
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Heparin Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Heparin Sodium
        1.3.3 Heparin Calcium
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Heparin Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 UFH
        1.4.3 LMWH
    1.5 Global Heparin Market Size & Forecast
        1.5.1 Global Heparin Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Heparin Sales Quantity (2018-2029)
        1.5.3 Global Heparin Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Shenzhen Hepalink Pharmaceutical
        2.1.1 Shenzhen Hepalink Pharmaceutical Details
        2.1.2 Shenzhen Hepalink Pharmaceutical Major Business
        2.1.3 Shenzhen Hepalink Pharmaceutical Heparin Product and Services
        2.1.4 Shenzhen Hepalink Pharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
    2.2 Yantai Dongcheng Pharmaceutical
        2.2.1 Yantai Dongcheng Pharmaceutical Details
        2.2.2 Yantai Dongcheng Pharmaceutical Major Business
        2.2.3 Yantai Dongcheng Pharmaceutical Heparin Product and Services
        2.2.4 Yantai Dongcheng Pharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
    2.3 Pfizer
        2.3.1 Pfizer Details
        2.3.2 Pfizer Major Business
        2.3.3 Pfizer Heparin Product and Services
        2.3.4 Pfizer Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Pfizer Recent Developments/Updates
    2.4 Bioibérica
        2.4.1 Bioibérica Details
        2.4.2 Bioibérica Major Business
        2.4.3 Bioibérica Heparin Product and Services
        2.4.4 Bioibérica Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Bioibérica Recent Developments/Updates
    2.5 Changzhou Qianhong Biopharma
        2.5.1 Changzhou Qianhong Biopharma Details
        2.5.2 Changzhou Qianhong Biopharma Major Business
        2.5.3 Changzhou Qianhong Biopharma Heparin Product and Services
        2.5.4 Changzhou Qianhong Biopharma Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Changzhou Qianhong Biopharma Recent Developments/Updates
    2.6 Nanjing King-friend Biochemical Pharmaceutical
        2.6.1 Nanjing King-friend Biochemical Pharmaceutical Details
        2.6.2 Nanjing King-friend Biochemical Pharmaceutical Major Business
        2.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Product and Services
        2.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
    2.7 Hebei Changshan Biochemical Pharmaceutical
        2.7.1 Hebei Changshan Biochemical Pharmaceutical Details
        2.7.2 Hebei Changshan Biochemical Pharmaceutical Major Business
        2.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Product and Services
        2.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
    2.8 Qingdao Jiulong Biopharmaceutical
        2.8.1 Qingdao Jiulong Biopharmaceutical Details
        2.8.2 Qingdao Jiulong Biopharmaceutical Major Business
        2.8.3 Qingdao Jiulong Biopharmaceutical Heparin Product and Services
        2.8.4 Qingdao Jiulong Biopharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
    2.9 Opocrin
        2.9.1 Opocrin Details
        2.9.2 Opocrin Major Business
        2.9.3 Opocrin Heparin Product and Services
        2.9.4 Opocrin Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Opocrin Recent Developments/Updates
    2.10 Dongying Tiandong Pharmaceutical
        2.10.1 Dongying Tiandong Pharmaceutical Details
        2.10.2 Dongying Tiandong Pharmaceutical Major Business
        2.10.3 Dongying Tiandong Pharmaceutical Heparin Product and Services
        2.10.4 Dongying Tiandong Pharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
    2.11 Aspen Oss
        2.11.1 Aspen Oss Details
        2.11.2 Aspen Oss Major Business
        2.11.3 Aspen Oss Heparin Product and Services
        2.11.4 Aspen Oss Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Aspen Oss Recent Developments/Updates
    2.12 Yino Pharma
        2.12.1 Yino Pharma Details
        2.12.2 Yino Pharma Major Business
        2.12.3 Yino Pharma Heparin Product and Services
        2.12.4 Yino Pharma Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Yino Pharma Recent Developments/Updates
    2.13 Nanjing Xinbai Pharmaceutical
        2.13.1 Nanjing Xinbai Pharmaceutical Details
        2.13.2 Nanjing Xinbai Pharmaceutical Major Business
        2.13.3 Nanjing Xinbai Pharmaceutical Heparin Product and Services
        2.13.4 Nanjing Xinbai Pharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Nanjing Xinbai Pharmaceutical Recent Developments/Updates
    2.14 Hubei Enoray Biopharmaceutical
        2.14.1 Hubei Enoray Biopharmaceutical Details
        2.14.2 Hubei Enoray Biopharmaceutical Major Business
        2.14.3 Hubei Enoray Biopharmaceutical Heparin Product and Services
        2.14.4 Hubei Enoray Biopharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
    2.15 Cisen Pharmaceutical
        2.15.1 Cisen Pharmaceutical Details
        2.15.2 Cisen Pharmaceutical Major Business
        2.15.3 Cisen Pharmaceutical Heparin Product and Services
        2.15.4 Cisen Pharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Cisen Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Heparin by Manufacturer
    3.1 Global Heparin Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Heparin Revenue by Manufacturer (2018-2023)
    3.3 Global Heparin Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Heparin by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Heparin Manufacturer Market Share in 2022
        3.4.2 Top 6 Heparin Manufacturer Market Share in 2022
    3.5 Heparin Market: Overall Company Footprint Analysis
        3.5.1 Heparin Market: Region Footprint
        3.5.2 Heparin Market: Company Product Type Footprint
        3.5.3 Heparin Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Heparin Market Size by Region
        4.1.1 Global Heparin Sales Quantity by Region (2018-2029)
        4.1.2 Global Heparin Consumption Value by Region (2018-2029)
        4.1.3 Global Heparin Average Price by Region (2018-2029)
    4.2 North America Heparin Consumption Value (2018-2029)
    4.3 Europe Heparin Consumption Value (2018-2029)
    4.4 Asia-Pacific Heparin Consumption Value (2018-2029)
    4.5 South America Heparin Consumption Value (2018-2029)
    4.6 Middle East and Africa Heparin Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Heparin Sales Quantity by Type (2018-2029)
    5.2 Global Heparin Consumption Value by Type (2018-2029)
    5.3 Global Heparin Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Heparin Sales Quantity by Application (2018-2029)
    6.2 Global Heparin Consumption Value by Application (2018-2029)
    6.3 Global Heparin Average Price by Application (2018-2029)

7 North America
    7.1 North America Heparin Sales Quantity by Type (2018-2029)
    7.2 North America Heparin Sales Quantity by Application (2018-2029)
    7.3 North America Heparin Market Size by Country
        7.3.1 North America Heparin Sales Quantity by Country (2018-2029)
        7.3.2 North America Heparin Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Heparin Sales Quantity by Type (2018-2029)
    8.2 Europe Heparin Sales Quantity by Application (2018-2029)
    8.3 Europe Heparin Market Size by Country
        8.3.1 Europe Heparin Sales Quantity by Country (2018-2029)
        8.3.2 Europe Heparin Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Heparin Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Heparin Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Heparin Market Size by Region
        9.3.1 Asia-Pacific Heparin Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Heparin Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Heparin Sales Quantity by Type (2018-2029)
    10.2 South America Heparin Sales Quantity by Application (2018-2029)
    10.3 South America Heparin Market Size by Country
        10.3.1 South America Heparin Sales Quantity by Country (2018-2029)
        10.3.2 South America Heparin Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Heparin Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Heparin Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Heparin Market Size by Country
        11.3.1 Middle East & Africa Heparin Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Heparin Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Heparin Market Drivers
    12.2 Heparin Market Restraints
    12.3 Heparin Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Heparin and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Heparin
    13.3 Heparin Production Process
    13.4 Heparin Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Heparin Typical Distributors
    14.3 Heparin Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Heparin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Heparin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Shenzhen Hepalink Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 4. Shenzhen Hepalink Pharmaceutical Major Business
    Table 5. Shenzhen Hepalink Pharmaceutical Heparin Product and Services
    Table 6. Shenzhen Hepalink Pharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
    Table 8. Yantai Dongcheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 9. Yantai Dongcheng Pharmaceutical Major Business
    Table 10. Yantai Dongcheng Pharmaceutical Heparin Product and Services
    Table 11. Yantai Dongcheng Pharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Yantai Dongcheng Pharmaceutical Recent Developments/Updates
    Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 14. Pfizer Major Business
    Table 15. Pfizer Heparin Product and Services
    Table 16. Pfizer Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Pfizer Recent Developments/Updates
    Table 18. Bioibérica Basic Information, Manufacturing Base and Competitors
    Table 19. Bioibérica Major Business
    Table 20. Bioibérica Heparin Product and Services
    Table 21. Bioibérica Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Bioibérica Recent Developments/Updates
    Table 23. Changzhou Qianhong Biopharma Basic Information, Manufacturing Base and Competitors
    Table 24. Changzhou Qianhong Biopharma Major Business
    Table 25. Changzhou Qianhong Biopharma Heparin Product and Services
    Table 26. Changzhou Qianhong Biopharma Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Changzhou Qianhong Biopharma Recent Developments/Updates
    Table 28. Nanjing King-friend Biochemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 29. Nanjing King-friend Biochemical Pharmaceutical Major Business
    Table 30. Nanjing King-friend Biochemical Pharmaceutical Heparin Product and Services
    Table 31. Nanjing King-friend Biochemical Pharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
    Table 33. Hebei Changshan Biochemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 34. Hebei Changshan Biochemical Pharmaceutical Major Business
    Table 35. Hebei Changshan Biochemical Pharmaceutical Heparin Product and Services
    Table 36. Hebei Changshan Biochemical Pharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
    Table 38. Qingdao Jiulong Biopharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 39. Qingdao Jiulong Biopharmaceutical Major Business
    Table 40. Qingdao Jiulong Biopharmaceutical Heparin Product and Services
    Table 41. Qingdao Jiulong Biopharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
    Table 43. Opocrin Basic Information, Manufacturing Base and Competitors
    Table 44. Opocrin Major Business
    Table 45. Opocrin Heparin Product and Services
    Table 46. Opocrin Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Opocrin Recent Developments/Updates
    Table 48. Dongying Tiandong Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 49. Dongying Tiandong Pharmaceutical Major Business
    Table 50. Dongying Tiandong Pharmaceutical Heparin Product and Services
    Table 51. Dongying Tiandong Pharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Dongying Tiandong Pharmaceutical Recent Developments/Updates
    Table 53. Aspen Oss Basic Information, Manufacturing Base and Competitors
    Table 54. Aspen Oss Major Business
    Table 55. Aspen Oss Heparin Product and Services
    Table 56. Aspen Oss Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Aspen Oss Recent Developments/Updates
    Table 58. Yino Pharma Basic Information, Manufacturing Base and Competitors
    Table 59. Yino Pharma Major Business
    Table 60. Yino Pharma Heparin Product and Services
    Table 61. Yino Pharma Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Yino Pharma Recent Developments/Updates
    Table 63. Nanjing Xinbai Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 64. Nanjing Xinbai Pharmaceutical Major Business
    Table 65. Nanjing Xinbai Pharmaceutical Heparin Product and Services
    Table 66. Nanjing Xinbai Pharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. Nanjing Xinbai Pharmaceutical Recent Developments/Updates
    Table 68. Hubei Enoray Biopharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 69. Hubei Enoray Biopharmaceutical Major Business
    Table 70. Hubei Enoray Biopharmaceutical Heparin Product and Services
    Table 71. Hubei Enoray Biopharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. Hubei Enoray Biopharmaceutical Recent Developments/Updates
    Table 73. Cisen Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 74. Cisen Pharmaceutical Major Business
    Table 75. Cisen Pharmaceutical Heparin Product and Services
    Table 76. Cisen Pharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Cisen Pharmaceutical Recent Developments/Updates
    Table 78. Global Heparin Sales Quantity by Manufacturer (2018-2023) & (B Units)
    Table 79. Global Heparin Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 80. Global Heparin Average Price by Manufacturer (2018-2023) & (US$/B Units)
    Table 81. Market Position of Manufacturers in Heparin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 82. Head Office and Heparin Production Site of Key Manufacturer
    Table 83. Heparin Market: Company Product Type Footprint
    Table 84. Heparin Market: Company Product Application Footprint
    Table 85. Heparin New Market Entrants and Barriers to Market Entry
    Table 86. Heparin Mergers, Acquisition, Agreements, and Collaborations
    Table 87. Global Heparin Sales Quantity by Region (2018-2023) & (B Units)
    Table 88. Global Heparin Sales Quantity by Region (2024-2029) & (B Units)
    Table 89. Global Heparin Consumption Value by Region (2018-2023) & (USD Million)
    Table 90. Global Heparin Consumption Value by Region (2024-2029) & (USD Million)
    Table 91. Global Heparin Average Price by Region (2018-2023) & (US$/B Units)
    Table 92. Global Heparin Average Price by Region (2024-2029) & (US$/B Units)
    Table 93. Global Heparin Sales Quantity by Type (2018-2023) & (B Units)
    Table 94. Global Heparin Sales Quantity by Type (2024-2029) & (B Units)
    Table 95. Global Heparin Consumption Value by Type (2018-2023) & (USD Million)
    Table 96. Global Heparin Consumption Value by Type (2024-2029) & (USD Million)
    Table 97. Global Heparin Average Price by Type (2018-2023) & (US$/B Units)
    Table 98. Global Heparin Average Price by Type (2024-2029) & (US$/B Units)
    Table 99. Global Heparin Sales Quantity by Application (2018-2023) & (B Units)
    Table 100. Global Heparin Sales Quantity by Application (2024-2029) & (B Units)
    Table 101. Global Heparin Consumption Value by Application (2018-2023) & (USD Million)
    Table 102. Global Heparin Consumption Value by Application (2024-2029) & (USD Million)
    Table 103. Global Heparin Average Price by Application (2018-2023) & (US$/B Units)
    Table 104. Global Heparin Average Price by Application (2024-2029) & (US$/B Units)
    Table 105. North America Heparin Sales Quantity by Type (2018-2023) & (B Units)
    Table 106. North America Heparin Sales Quantity by Type (2024-2029) & (B Units)
    Table 107. North America Heparin Sales Quantity by Application (2018-2023) & (B Units)
    Table 108. North America Heparin Sales Quantity by Application (2024-2029) & (B Units)
    Table 109. North America Heparin Sales Quantity by Country (2018-2023) & (B Units)
    Table 110. North America Heparin Sales Quantity by Country (2024-2029) & (B Units)
    Table 111. North America Heparin Consumption Value by Country (2018-2023) & (USD Million)
    Table 112. North America Heparin Consumption Value by Country (2024-2029) & (USD Million)
    Table 113. Europe Heparin Sales Quantity by Type (2018-2023) & (B Units)
    Table 114. Europe Heparin Sales Quantity by Type (2024-2029) & (B Units)
    Table 115. Europe Heparin Sales Quantity by Application (2018-2023) & (B Units)
    Table 116. Europe Heparin Sales Quantity by Application (2024-2029) & (B Units)
    Table 117. Europe Heparin Sales Quantity by Country (2018-2023) & (B Units)
    Table 118. Europe Heparin Sales Quantity by Country (2024-2029) & (B Units)
    Table 119. Europe Heparin Consumption Value by Country (2018-2023) & (USD Million)
    Table 120. Europe Heparin Consumption Value by Country (2024-2029) & (USD Million)
    Table 121. Asia-Pacific Heparin Sales Quantity by Type (2018-2023) & (B Units)
    Table 122. Asia-Pacific Heparin Sales Quantity by Type (2024-2029) & (B Units)
    Table 123. Asia-Pacific Heparin Sales Quantity by Application (2018-2023) & (B Units)
    Table 124. Asia-Pacific Heparin Sales Quantity by Application (2024-2029) & (B Units)
    Table 125. Asia-Pacific Heparin Sales Quantity by Region (2018-2023) & (B Units)
    Table 126. Asia-Pacific Heparin Sales Quantity by Region (2024-2029) & (B Units)
    Table 127. Asia-Pacific Heparin Consumption Value by Region (2018-2023) & (USD Million)
    Table 128. Asia-Pacific Heparin Consumption Value by Region (2024-2029) & (USD Million)
    Table 129. South America Heparin Sales Quantity by Type (2018-2023) & (B Units)
    Table 130. South America Heparin Sales Quantity by Type (2024-2029) & (B Units)
    Table 131. South America Heparin Sales Quantity by Application (2018-2023) & (B Units)
    Table 132. South America Heparin Sales Quantity by Application (2024-2029) & (B Units)
    Table 133. South America Heparin Sales Quantity by Country (2018-2023) & (B Units)
    Table 134. South America Heparin Sales Quantity by Country (2024-2029) & (B Units)
    Table 135. South America Heparin Consumption Value by Country (2018-2023) & (USD Million)
    Table 136. South America Heparin Consumption Value by Country (2024-2029) & (USD Million)
    Table 137. Middle East & Africa Heparin Sales Quantity by Type (2018-2023) & (B Units)
    Table 138. Middle East & Africa Heparin Sales Quantity by Type (2024-2029) & (B Units)
    Table 139. Middle East & Africa Heparin Sales Quantity by Application (2018-2023) & (B Units)
    Table 140. Middle East & Africa Heparin Sales Quantity by Application (2024-2029) & (B Units)
    Table 141. Middle East & Africa Heparin Sales Quantity by Region (2018-2023) & (B Units)
    Table 142. Middle East & Africa Heparin Sales Quantity by Region (2024-2029) & (B Units)
    Table 143. Middle East & Africa Heparin Consumption Value by Region (2018-2023) & (USD Million)
    Table 144. Middle East & Africa Heparin Consumption Value by Region (2024-2029) & (USD Million)
    Table 145. Heparin Raw Material
    Table 146. Key Manufacturers of Heparin Raw Materials
    Table 147. Heparin Typical Distributors
    Table 148. Heparin Typical Customers
List of Figures
    Figure 1. Heparin Picture
    Figure 2. Global Heparin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Heparin Consumption Value Market Share by Type in 2022
    Figure 4. Heparin Sodium Examples
    Figure 5. Heparin Calcium Examples
    Figure 6. Global Heparin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Heparin Consumption Value Market Share by Application in 2022
    Figure 8. UFH Examples
    Figure 9. LMWH Examples
    Figure 10. Global Heparin Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 11. Global Heparin Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 12. Global Heparin Sales Quantity (2018-2029) & (B Units)
    Figure 13. Global Heparin Average Price (2018-2029) & (US$/B Units)
    Figure 14. Global Heparin Sales Quantity Market Share by Manufacturer in 2022
    Figure 15. Global Heparin Consumption Value Market Share by Manufacturer in 2022
    Figure 16. Producer Shipments of Heparin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 17. Top 3 Heparin Manufacturer (Consumption Value) Market Share in 2022
    Figure 18. Top 6 Heparin Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Global Heparin Sales Quantity Market Share by Region (2018-2029)
    Figure 20. Global Heparin Consumption Value Market Share by Region (2018-2029)
    Figure 21. North America Heparin Consumption Value (2018-2029) & (USD Million)
    Figure 22. Europe Heparin Consumption Value (2018-2029) & (USD Million)
    Figure 23. Asia-Pacific Heparin Consumption Value (2018-2029) & (USD Million)
    Figure 24. South America Heparin Consumption Value (2018-2029) & (USD Million)
    Figure 25. Middle East & Africa Heparin Consumption Value (2018-2029) & (USD Million)
    Figure 26. Global Heparin Sales Quantity Market Share by Type (2018-2029)
    Figure 27. Global Heparin Consumption Value Market Share by Type (2018-2029)
    Figure 28. Global Heparin Average Price by Type (2018-2029) & (US$/B Units)
    Figure 29. Global Heparin Sales Quantity Market Share by Application (2018-2029)
    Figure 30. Global Heparin Consumption Value Market Share by Application (2018-2029)
    Figure 31. Global Heparin Average Price by Application (2018-2029) & (US$/B Units)
    Figure 32. North America Heparin Sales Quantity Market Share by Type (2018-2029)
    Figure 33. North America Heparin Sales Quantity Market Share by Application (2018-2029)
    Figure 34. North America Heparin Sales Quantity Market Share by Country (2018-2029)
    Figure 35. North America Heparin Consumption Value Market Share by Country (2018-2029)
    Figure 36. United States Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 37. Canada Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Mexico Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Europe Heparin Sales Quantity Market Share by Type (2018-2029)
    Figure 40. Europe Heparin Sales Quantity Market Share by Application (2018-2029)
    Figure 41. Europe Heparin Sales Quantity Market Share by Country (2018-2029)
    Figure 42. Europe Heparin Consumption Value Market Share by Country (2018-2029)
    Figure 43. Germany Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 44. France Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. United Kingdom Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. Russia Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Italy Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Asia-Pacific Heparin Sales Quantity Market Share by Type (2018-2029)
    Figure 49. Asia-Pacific Heparin Sales Quantity Market Share by Application (2018-2029)
    Figure 50. Asia-Pacific Heparin Sales Quantity Market Share by Region (2018-2029)
    Figure 51. Asia-Pacific Heparin Consumption Value Market Share by Region (2018-2029)
    Figure 52. China Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 53. Japan Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Korea Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. India Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Southeast Asia Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Australia Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. South America Heparin Sales Quantity Market Share by Type (2018-2029)
    Figure 59. South America Heparin Sales Quantity Market Share by Application (2018-2029)
    Figure 60. South America Heparin Sales Quantity Market Share by Country (2018-2029)
    Figure 61. South America Heparin Consumption Value Market Share by Country (2018-2029)
    Figure 62. Brazil Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 63. Argentina Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Middle East & Africa Heparin Sales Quantity Market Share by Type (2018-2029)
    Figure 65. Middle East & Africa Heparin Sales Quantity Market Share by Application (2018-2029)
    Figure 66. Middle East & Africa Heparin Sales Quantity Market Share by Region (2018-2029)
    Figure 67. Middle East & Africa Heparin Consumption Value Market Share by Region (2018-2029)
    Figure 68. Turkey Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 69. Egypt Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Saudi Arabia Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. South Africa Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Heparin Market Drivers
    Figure 73. Heparin Market Restraints
    Figure 74. Heparin Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Heparin in 2022
    Figure 77. Manufacturing Process Analysis of Heparin
    Figure 78. Heparin Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Companies Mentioned

Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
Bioibérica
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical